Atheer Awad is a Lecturer in Pharmaceutics at the University of Hertfordshire (UK). She is also the Deputy Chair of the International Pharmaceutical 3D Printing Initiative (Pharma3DPI). Dr. Awad received her Bachelor’s degree in Pharmacy at the Applied Science Private University (Jordan) in 2015. She then pursued an MSc (2015–2016) and a Ph.D. (2016–2021) in Pharmaceutics at the UCL School of Pharmacy (UK), where her work focused on 3D printing dosage forms and medicated devices for special patient groups. Following that, she worked as a Research Fellow at the same institution as part of the INTERREG 2 Seas program, where her project focused on site-specific drug delivery using 3D printing. Her research harnesses her expertise in digital health technologies, including 3D and 4D printing and site-specific drug delivery towards application in personalized and transformative medicines. She has over 30 publications and received multiple awards and honors, including Clarivate’s Highly Cited Researcher (2022–2023), Forbes 30 Under 30 (2022), Stanford’s Top 2% Scientists (2022–2023), International Pharmaceutical Federation’s FIPWiSE Rising Star (2022), MIT Technology Reviews’s Innovator Under 35 (2021) and Expertscape’s World Expert in Printing (2021-2023). Moreover, her work received MDPI’s Journal of Clinical Medicine PhD Thesis and Pharmaceutics Best Paper Awards (2021).